• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水清亮细胞甲状旁腺腺瘤的机构学特征:一种罕见的实体,常被 TC-99m-甲氧基异丁基异腈闪烁扫描术所忽视。

Institutional characterisation of water clear cell parathyroid adenoma: a rare entity often unrecognised by TC-99m-sestamibi scintigraphy.

机构信息

Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

出版信息

Pathology. 2021 Dec;53(7):852-859. doi: 10.1016/j.pathol.2021.02.011. Epub 2021 May 14.

DOI:10.1016/j.pathol.2021.02.011
PMID:33994174
Abstract

Parathyroid lesions exhibiting a water clear cell morphology are exceedingly rare manifestations in primary hyperparathyroidism (PHPT), and the phenomenon has been reported both for uniglandular (water clear cell adenoma; WCCA) and multiglandular disease (water clear cell hyperplasia; WCCH). In all, only 24 previous descriptions of WCCA exist in the literature. Herein, we present seven cases with water clear cell morphology (6 WCCAs and 1 case of WCCH) in an institutional series of approximately 4000 parathyroid lesions spanning 29 years in a tertiary centre setting. Major histological attributes and clinical parameters associated with this morphological subtype were reviewed, and a literature search was conducted. WCCA and WCHH exhibited an institutional prevalence of 0.15% and 0.025%, respectively. All cases displayed histological hallmarks of water clear cell morphology, with cells exhibiting abundant cytoplasm filled with vacuoles. Atypical findings or unequivocal evidence of invasive behaviour were not observed. The gender distribution was 6:1 (F:M), patients were generally symptomatic with mild hypercalcaemia, and the median age at surgery was 53 years (range 38-78). The preoperative localisation was inconclusive in four of seven, and neck exploration of all four glands was undertaken in five cases. The excised WCCAs exhibited an average weight of 1215 mg, markedly higher than conventional adenomas, and all patients were cured of PHPT following parathyroidectomy. Interestingly, previous reports mirror our observations that these lesions often are large, in relation to their sizes biochemically fairly indolent, and indecisively localised using scintigraphy, providing correlations of possible clinical value when pre-operatively assessing these rare lesions.

摘要

甲状旁腺病变表现为水样透明细胞形态在原发性甲状旁腺功能亢进症 (PHPT) 中极为罕见,该现象在单腺(水样透明细胞腺瘤;WCCA)和多腺疾病(水样透明细胞增生;WCCH)中均有报道。文献中总共只有 24 例之前描述的 WCCA 存在。在此,我们在一个三级中心环境中,对 29 年间大约 4000 例甲状旁腺病变的机构系列中存在水样透明细胞形态的 7 例病例(6 例 WCCA 和 1 例 WCCH)进行了介绍。对这种形态学亚型的主要组织学特征和临床参数进行了回顾,并进行了文献检索。WCCA 和 WCCH 在机构中的患病率分别为 0.15%和 0.025%。所有病例均显示水样透明细胞形态的组织学特征,细胞具有丰富的细胞质,充满空泡。未观察到非典型表现或明确的侵袭性行为证据。性别分布为 6:1(F:M),患者通常有症状,伴有轻度高钙血症,手术时的中位年龄为 53 岁(范围 38-78 岁)。术前定位在 7 例中的 4 例中不明确,在 5 例中对所有 4 个腺体进行了颈部探查。切除的 WCCA 平均重量为 1215 毫克,明显高于常规腺瘤,所有患者在甲状旁腺切除术后均治愈 PHPT。有趣的是,以前的报告反映了我们的观察结果,即这些病变通常很大,与其大小相比,其生化活性相当惰性,并且使用闪烁扫描术难以明确定位,为术前评估这些罕见病变提供了可能具有临床价值的相关性。

相似文献

1
Institutional characterisation of water clear cell parathyroid adenoma: a rare entity often unrecognised by TC-99m-sestamibi scintigraphy.水清亮细胞甲状旁腺腺瘤的机构学特征:一种罕见的实体,常被 TC-99m-甲氧基异丁基异腈闪烁扫描术所忽视。
Pathology. 2021 Dec;53(7):852-859. doi: 10.1016/j.pathol.2021.02.011. Epub 2021 May 14.
2
ROLE OF IMAGING TESTS FOR PREOPERATIVE LOCATION OF PATHOLOGIC PARATHYROID TISSUE IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM.影像学检查在原发性甲状旁腺功能亢进症患者甲状旁腺病变组织术前定位中的作用。
Endocr Pract. 2016 Sep;22(9):1062-7. doi: 10.4158/EP151137.OR. Epub 2016 May 23.
3
Primary hyperparathyroidism with water clear cell content: the impact of histological diagnosis on clinical management and outcome.伴有透明细胞成分的原发性甲状旁腺功能亢进症:组织学诊断对临床管理及预后的影响
Ann R Coll Surg Engl. 2013 Apr;95(3):e60-2. doi: 10.1308/003588413X13511609957533.
4
P-gp and MRP1 expression in parathyroid tumors related to histology, weight and (99m)Tc-sestamibi imaging results.甲状旁腺肿瘤中P-糖蛋白和多药耐药相关蛋白1的表达与组织学、重量及(99m)锝-甲氧基异丁基异腈显像结果的关系。
Exp Clin Endocrinol Diabetes. 2009 Sep;117(8):406-12. doi: 10.1055/s-0028-1105925. Epub 2009 Feb 20.
5
Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism.双相Tc-99m 甲氧基异丁基异腈闪烁扫描术在术前定位甲状旁腺功能亢进致病灶中的应用
Clin Nucl Med. 1998 May;23(5):291-7. doi: 10.1097/00003072-199805000-00005.
6
[False negative spect parathyroid scintigraphy with sestamibi in patients with primary hyperparathyroidism].[原发性甲状旁腺功能亢进患者使用甲氧基异丁基异腈进行的假阴性甲状旁腺SPECT闪烁扫描]
Rev Med Chil. 2017 Aug;145(8):1021-1027. doi: 10.4067/s0034-98872017000801021.
7
99MTc-sestamibi as sole technique in selection of primary hyperparathyroidism patients for unilateral neck exploration.99锝-甲氧基异丁基异腈作为原发性甲状旁腺功能亢进患者单侧颈部探查术选择的唯一技术。
Surgery. 2008 Sep;144(3):454-9. doi: 10.1016/j.surg.2008.05.014.
8
Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.锝-99m-甲氧基异丁基异腈单剂定位与高分辨率超声检查对原发性甲状旁腺功能亢进症患者甲状旁腺术前定位的比较
Am Surg. 1995 Oct;61(10):882-8.
9
Feasibility and safety of minimally invasive radioguided parathyroidectomy using very low intraoperative dose of Tc-99m MIBI.应用 Tc-99m MIBI 极低术中剂量行微创放射性导向甲状旁腺切除术的可行性和安全性。
Int J Surg. 2017 Mar;39:229-233. doi: 10.1016/j.ijsu.2017.02.009. Epub 2017 Feb 10.
10
Minimally invasive radionuclide-guided parathyroidectomy using 99mTc-sestamibi in patients with primary hyperparathyroidism: a single-institution experience.使用99mTc-甲氧基异丁基异腈对原发性甲状旁腺功能亢进患者进行微创放射性核素引导下甲状旁腺切除术:单机构经验
Med Princ Pract. 2009;18(5):373-7. doi: 10.1159/000226291. Epub 2009 Jul 31.

引用本文的文献

1
Preoperative localization of water clear cell giant parathyroid adenoma: A case report.水样透明细胞型巨大甲状旁腺腺瘤的术前定位:一例报告
Radiol Case Rep. 2024 Apr 4;19(6):2492-2497. doi: 10.1016/j.radcr.2024.03.026. eCollection 2024 Jun.
2
Top 10 Clear Cell Head and Neck Lesions to Contemplate.头颈部透明细胞病变 10 大要点
Head Neck Pathol. 2023 Mar;17(1):33-52. doi: 10.1007/s12105-022-01518-6. Epub 2023 Mar 16.
3
Giant Parathyroid Tumor: Parathyroid Adenoma versus Parathyroid Carcinoma.巨大甲状旁腺肿瘤:甲状旁腺腺瘤与甲状旁腺癌
Case Rep Endocrinol. 2022 Oct 26;2022:7712097. doi: 10.1155/2022/7712097. eCollection 2022.
4
Overview of the 2022 WHO Classification of Parathyroid Tumors.《2022 年世卫组织甲状旁腺肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):64-89. doi: 10.1007/s12022-022-09709-1. Epub 2022 Feb 17.
5
Parathyroid Adenoma With Respiratory-Like Epithelium: Case Report of a Potential Mimic With Unknown Etiology.甲状旁腺腺瘤伴呼吸样上皮:一例潜在病因不明的类似物病例报告。
Front Endocrinol (Lausanne). 2021 Aug 4;12:724766. doi: 10.3389/fendo.2021.724766. eCollection 2021.